IVF Treatment Turkey

IVF Treatment in Turkey

IVF treatment in Turkey is a widely used assisted reproductive treatment for couples who have difficulty conceiving naturally.

IVF, or in vitro fertilization, involves stimulating the ovaries, retrieving eggs, fertilizing them with sperm in a laboratory, developing embryos under controlled laboratory conditions, and transferring a selected embryo into the uterus.

IVF is not a single standardized treatment that is performed identically for every patient. The stimulation protocol, medication doses, fertilization method, embryo culture strategy, decision to perform genetic testing, and embryo transfer plan should be individualized according to the woman's age, ovarian reserve, infertility diagnosis, sperm parameters, previous treatment history and other clinical factors.

For international patients, IVF in Turkey may also be attractive because treatment is available through licensed assisted reproductive treatment centers and can often be coordinated within a relatively short period. However, patients should compare clinics based on medical quality, laboratory standards, transparency of success rates and the experience of the clinical and embryology teams rather than focusing only on price.

What Is IVF Treatment?

In vitro fertilization (IVF) is an assisted reproductive technique in which eggs are retrieved from the ovaries and fertilized with sperm outside the body in an embryology laboratory.

After fertilization, the resulting embryos are cultured for several days. When an embryo reaches an appropriate developmental stage, it may be transferred into the uterus. Suitable surplus embryos can be cryopreserved for possible future use.

There are two principal laboratory methods of fertilization:

• Conventional IVF: prepared sperm are placed together with the retrieved egg and fertilization occurs without direct injection of a sperm into the egg.
• ICSI (intracytoplasmic sperm injection): an embryologist injects a single sperm directly into a mature egg.

ICSI is particularly useful in selected cases of male-factor infertility or previous fertilization failure. It should not automatically be considered superior to conventional IVF for every patient. Current ASRM guidance states that routine ICSI in patients without male-factor infertility or previous fertilization failure has not been shown to improve live-birth outcomes.

Therefore, the choice between conventional IVF and ICSI should be based on the couple's clinical and laboratory characteristics.

Under Turkish regulations, assisted reproductive treatment is regulated by the Ministry of Health, and treatment is provided within licensed and authorized centers. The current regulatory framework defines assisted reproductive treatment as procedures involving the reproductive cells of the prospective mother and her husband and the transfer of gametes or embryos when medically appropriate.

For international patients considering IVF treatment in Turkey, it is important to confirm before treatment:

• Whether the clinic is officially licensed for assisted reproductive treatment
• Who will manage the medical treatment
• Whether the embryology laboratory is operated by appropriately qualified personnel
• Which IVF and embryo laboratory procedures are included in the treatment package
• Whether medications are included in the quoted price
• Whether embryo freezing and storage are included
• Whether genetic testing, if required, is performed by an appropriate laboratory
• How the clinic reports its IVF success rates
• What follow-up is provided after embryo transfer

A low advertised treatment price should not be the only factor used when choosing an IVF clinic.

Who May Need IVF Treatment?

IVF may be considered in a number of situations, including:

• Blocked or severely damaged fallopian tubes
• Severe male-factor infertility
• Azoospermia when sperm can potentially be surgically retrieved
• Some cases of ovulation disorders when other treatments have not been successful
• Endometriosis-associated infertility in selected patients
• Unexplained infertility after appropriate evaluation and unsuccessful simpler treatments
• Previous unsuccessful IUI treatments
• Infertility associated with reduced ovarian reserve in selected patients
• Previous IVF cycles with specific indications for changing the treatment strategy
• The need for IVF to perform preimplantation genetic testing for a specific genetic condition
• Fertility preservation before treatments that may impair reproductive function

The decision to proceed directly to IVF depends on age, infertility duration, diagnosis, ovarian reserve, semen analysis and previous treatment history.

When Should IVF Be Considered?

There is no single IVF starting point that is appropriate for every couple.

Age is particularly important because female fertility declines with increasing age, largely because both the number of available oocytes and the probability of chromosomally normal embryos decline.

For younger patients with a favorable prognosis, treatment may sometimes begin with ovulation induction and/or intrauterine insemination (IUI). In other situations—such as bilateral tubal obstruction or severe male-factor infertility—IVF may be recommended without prolonged attempts at simpler treatments.

For women in their late 30s or 40s, delaying effective treatment may reduce the number of available eggs and embryos. Therefore, the treatment strategy should be determined after an individualized fertility assessment rather than according to age alone.

Initial IVF Consultation and Evaluation

The first step in IVF treatment is a comprehensive assessment of both partners.

The evaluation may include:

Female fertility assessment

Depending on the patient's history, the assessment may include:

• Menstrual and reproductive history
• Transvaginal ultrasound
• Antral follicle count (AFC)
• Anti-Müllerian hormone (AMH)
• Assessment of the uterus and endometrium
• Assessment of the fallopian tubes when clinically indicated
• Relevant hormonal tests
• Review of previous pregnancies and fertility treatments

AMH and AFC are useful primarily for estimating ovarian response to stimulation. They do not independently determine egg quality or guarantee IVF success.

Male fertility assessment

Male evaluation generally begins with a semen analysis, assessing parameters such as:

• Sperm concentration
• Total sperm number
• Motility
• Morphology

If azoospermia or severe sperm abnormalities are present, further evaluation by a urologist or reproductive specialist may be required.

In selected azoospermic patients, sperm may be obtained surgically using techniques such as TESA, TESE or micro-TESE, depending on the underlying cause.

How Does IVF Treatment Work?

Although protocols vary, a typical IVF cycle involves several stages:

1. Initial assessment and treatment planning
2. Ovarian stimulation
3. Ultrasound and, when appropriate, hormone monitoring
4. Prevention of premature ovulation
5. Final oocyte maturation trigger
6. Egg retrieval
7. Sperm collection and laboratory preparation
8. Fertilization using conventional IVF or ICSI when indicated
9. Embryo culture
10. Embryo selection
11. Fresh or frozen embryo transfer
12. Pregnancy testing

Not every patient follows exactly the same sequence. Some patients undergo a fresh embryo transfer, while others have all suitable embryos frozen and undergo a later frozen embryo transfer.

Step 1: Ovarian Stimulation

The purpose of ovarian stimulation is to encourage the development of multiple follicles so that several mature oocytes may be retrieved.

The stimulation protocol is selected according to factors such as:

• Age
• Ovarian reserve
• Previous response to IVF medication
• BMI and other clinical characteristics
• Risk of ovarian hyperstimulation syndrome (OHSS)
• Previous IVF outcomes

Commonly used medications contain gonadotropins such as FSH, with LH activity used when clinically appropriate.

The patient is monitored with transvaginal ultrasound and, depending on the protocol and clinical situation, blood tests.

The aim is not simply to obtain the maximum possible number of eggs. Modern IVF emphasizes achieving an appropriate ovarian response while maintaining safety and obtaining mature oocytes capable of producing usable embryos.

The 2025 ESHRE ovarian stimulation guideline emphasizes individualized stimulation, monitoring, final oocyte maturation and prevention of OHSS.

Step 2: Preventing Premature Ovulation

In many contemporary IVF protocols, a GnRH antagonist is used during ovarian stimulation to prevent premature ovulation.

The timing and dosage are individualized.

The exact medication schedule should never be changed by the patient without speaking to the IVF team because the timing of injections is an important part of the treatment.

Step 3: Trigger Injection

When the developing follicles have reached an appropriate stage, a trigger injection is administered to induce final oocyte maturation.

Depending on the patient's ovarian response and risk profile, different trigger strategies may be used.

Egg retrieval is generally scheduled approximately 34–36 hours after the trigger, although the exact timing is determined by the clinic's protocol.

There is no universal rule such as "three follicles must reach 17 mm." Follicle size, number, estradiol levels, patient characteristics and the overall ovarian response are considered together when deciding the timing of the trigger.

Step 4: Egg Retrieval (Oocyte Pick-Up)

Egg retrieval, also known as OPU, is usually performed under sedation or anesthesia.

A transvaginal ultrasound probe is used to visualize the ovaries. A thin needle is guided through the vaginal wall into the ovarian follicles, and follicular fluid is aspirated.

The embryologist examines the collected fluid under a microscope to identify the oocytes.

The procedure commonly takes around 15–30 minutes, although the duration depends on the number and accessibility of the follicles.

Possible complications are uncommon but may include:

• Pelvic discomfort
• Vaginal spotting
• Infection
• Bleeding
• Injury to nearby structures
• Ovarian torsion in rare circumstances
• Complications related to anesthesia

Patients should follow the specific fasting and medication instructions provided by their clinic because these requirements depend on the anesthesia plan.

Step 5: Sperm Collection

A fresh semen sample is usually obtained on the day of egg retrieval.

The laboratory processes the sample to select sperm suitable for fertilization.

When sperm cannot be obtained from the ejaculate, surgical sperm retrieval may be considered in appropriately selected patients.

Step 6: Conventional IVF or ICSI

After egg retrieval, mature oocytes are fertilized in the laboratory.

Conventional IVF

In conventional IVF, prepared sperm are placed around the egg and fertilization occurs naturally within the laboratory culture dish.

ICSI

During ICSI, an embryologist injects one selected sperm directly into a mature oocyte.

ICSI is particularly useful in situations such as:

• Significant male-factor infertility
• Very low sperm concentration or motility
• Surgically retrieved sperm
• Previous complete or very poor fertilization with conventional IVF
• Selected cases involving previously frozen oocytes

However, ICSI should not automatically be used for every IVF cycle. Updated ASRM guidance published in 2026 concludes that routine ICSI in the absence of male-factor infertility or previous fertilization failure does not improve live birth rates. 

This is an important change from older IVF content that described ICSI as the preferred fertilization method for virtually all patients.

Step 7: Embryo Culture

After fertilization, embryos are cultured in specialized incubators.

Embryo development is monitored over several days.

An embryo may progress through several developmental stages before reaching the blastocyst stage, generally around day 5 or 6.

Embryologists assess factors such as:

• Cell division
• Developmental progression
• Degree of fragmentation
• Blastocyst expansion
• Inner cell mass
• Trophectoderm appearance

Embryo morphology is useful for selecting embryos, but morphology alone cannot guarantee implantation or a live birth.

Time-Lapse Embryo Monitoring

Some IVF laboratories use time-lapse incubators that continuously record embryo development.

Time-lapse imaging can provide detailed information about embryo development without repeatedly removing embryos from the controlled incubator environment.

However, it should not be presented as a guaranteed method of increasing pregnancy or live-birth rates. Its value is primarily related to embryo assessment and laboratory workflow, and evidence regarding its ability to improve final treatment outcomes remains limited.

Step 8: Embryo Transfer

Embryo transfer is usually a short procedure and generally does not require anesthesia.

A thin catheter is gently introduced through the cervix into the uterine cavity, and the embryo is released.

Ultrasound guidance is commonly used to improve visualization of the uterus and catheter position.

A full bladder may be requested because it can improve ultrasound visualization and help optimize the angle between the cervix and uterine cavity.

The transfer itself usually takes only a few minutes.

How Many Embryos Are Transferred?

The objective of IVF treatment is not simply to achieve pregnancy but to achieve a healthy singleton pregnancy and live birth.

Transferring more than one embryo increases the risk of multiple pregnancy, which can increase the risks of:

• Preterm birth
• Low birth weight
• Pregnancy-related hypertension
• Gestational diabetes
• Maternal and neonatal complications

The number of embryos that can be transferred is also regulated in Turkey. The Ministry of Health framework emphasizes limiting multiple pregnancies, and current practice in Turkey generally favors single embryo transfer in appropriate patients.

The final decision depends on the patient's age, embryo characteristics, previous treatment history and applicable regulations.

Fresh Embryo Transfer vs Frozen Embryo Transfer

An embryo can sometimes be transferred during the same cycle in which the eggs were retrieved.

In other cases, embryos are frozen and transferred in a later cycle.

A freeze-all strategy may be considered when:

• There is a high risk of OHSS
• Progesterone rises prematurely
• The endometrium is not considered optimal
• PGT is being performed
• A medical or logistical reason makes delayed transfer preferable

Frozen embryo transfer allows the embryo to be transferred in a later cycle after appropriate preparation of the endometrium.

Embryo Freezing

Modern IVF laboratories commonly use vitrification, a rapid cryopreservation technique that allows embryos to be stored for future treatment.

Suitable surplus embryos can therefore potentially be used for:

• A later transfer after an unsuccessful fresh cycle
• A future pregnancy
• A sibling pregnancy
• A frozen embryo transfer after PGT

The duration and conditions of embryo storage are governed by applicable Turkish regulations and clinic procedures.

Preimplantation Genetic Testing (PGT)

Preimplantation genetic testing involves examining cells obtained from embryos before embryo transfer.

Different forms of PGT answer different questions.

PGT-M

PGT-M is used when a family has a known risk of a specific single-gene disorder.

PGT-SR

PGT-SR can be used in selected situations involving structural chromosomal rearrangements in one of the parents.

PGT-A

PGT-A evaluates embryos for chromosomal copy-number abnormalities.

PGT-A should not be described as a universal test that guarantees a healthy baby or improves IVF success for every patient. Its value depends strongly on the patient's circumstances, embryo availability and clinical indication.

Current ASRM guidance also notes that routine ICSI solely because PGT-A is being performed is not supported by evidence in the absence of male-factor infertility.

PGT should therefore be discussed with both the fertility specialist and, when appropriate, a genetic specialist.

When Is Embryo Transfer Delayed?

There are situations in which transferring an embryo immediately after egg retrieval may not be the best option.

A frozen embryo transfer may be preferred when:

• OHSS risk is significant
• Hormonal conditions are unfavorable
• The endometrium requires additional preparation
• PGT is required
• The patient has another medical reason to postpone transfer

The decision should be individualized rather than based on the assumption that fresh transfer or frozen transfer is universally superior.

Pregnancy Test After IVF

After embryo transfer, the patient continues the medications prescribed for luteal-phase support, commonly including progesterone.

A blood β-hCG pregnancy test is generally performed approximately 9–14 days after embryo transfer, depending on the embryo stage and clinic protocol.

Testing too early can lead to confusion, particularly when an hCG-containing trigger medication was used.

Patients should not stop progesterone or other prescribed medications based solely on symptoms or home pregnancy-test results unless instructed by their medical team.

IVF Success Rates

One of the most important points for anyone researching IVF success rates in Turkey is that there is no single success rate that applies to every patient or clinic.

Success depends on factors including:

• Female age
• Ovarian reserve
• Number of mature oocytes retrieved
• Sperm quality
• Embryo development
• Embryo chromosomal status when tested
• Uterine and endometrial factors
• Previous IVF history
• Underlying infertility diagnosis
• Laboratory quality
• Whether the reported rate represents pregnancy, clinical pregnancy or live birth

Age has a particularly strong influence on IVF outcomes.

For example, CDC national ART data demonstrate a substantial reduction in live-birth outcomes as maternal age increases. In one national dataset, the percentage of intended retrievals resulting in live-birth delivery was 50.8% for women younger than 35, 36.4% for ages 35–37, 23.4% for ages 38–40 and 7.9% for women older than 40. These are population-level figures, not an individual's personal probability of success.

Therefore, patients should be cautious when a clinic advertises a single "90% IVF success rate." A meaningful comparison requires knowing:

• What outcome is being measured?
• Is the rate per embryo transfer or per egg retrieval?
• Is it a clinical pregnancy rate or live-birth rate?
• Are fresh and frozen cycles combined?
• What are the patients' age groups?
• Are donor eggs included?
• How many cycles are represented?

Factors That Affect IVF Success

Age and Egg Quality

Female age is one of the strongest predictors of IVF outcome.

As age increases, the probability of chromosomal abnormalities in oocytes and embryos increases, while ovarian reserve generally declines.

AMH can help estimate ovarian response but does not directly measure egg quality.

Sperm Quality

Severe abnormalities in sperm concentration, motility or morphology can reduce fertilization potential and may influence the choice of laboratory fertilization technique.

Embryo Development

Not every fertilized egg develops into a blastocyst.

The number of eggs retrieved therefore cannot be equated with the number of embryos available for transfer.

Uterine Factors

Polyps, significant fibroids affecting the uterine cavity, intrauterine adhesions, congenital uterine abnormalities and untreated hydrosalpinx can interfere with reproductive outcomes in selected patients.

Laboratory Quality

The embryology laboratory is a critical component of IVF.

Laboratory conditions include:

• Temperature stability
• Gas control
• Culture media
• Incubator performance
• Quality control
• Embryo handling
• Cryopreservation procedures
• Identification and witnessing systems

The laboratory should therefore be evaluated alongside the physician and clinic rather than treated as a secondary part of IVF.

Is IVF Treatment in Turkey Safe?

IVF is an established medical treatment, but like any medical procedure, it has potential risks.

One of the best-known complications is ovarian hyperstimulation syndrome (OHSS).

OHSS can occur when the ovaries respond excessively to stimulation. Modern IVF protocols include several strategies designed to reduce this risk, including individualized stimulation, careful monitoring and appropriate trigger selection.

Severe OHSS is uncommon but can require medical treatment.

Other possible complications include:

• Bleeding or infection after egg retrieval
• Ovarian torsion, rarely
• Anesthesia-related complications
• Multiple pregnancy
• Ectopic pregnancy
• Pregnancy complications associated with the underlying infertility and maternal age

The risk profile varies from patient to patient.

IVF and Multiple Pregnancy

One of the major developments in modern IVF is the move toward single embryo transfer.

Although transferring two embryos can increase the chance of pregnancy in some situations, it also increases the probability of twins.

A twin pregnancy is not simply "two successful pregnancies." It carries substantially greater maternal and neonatal risks.

For this reason, the goal of a high-quality IVF program should be a healthy singleton pregnancy rather than maximizing the number of embryos transferred.

Are IVF Pregnancies Different From Natural Pregnancies?

A pregnancy achieved through IVF is still a pregnancy.

After implantation, fetal development follows the same fundamental biological processes as pregnancy achieved without assisted reproductive technology.

However, people undergoing IVF may have a higher baseline prevalence of conditions such as advanced maternal age, infertility-related factors or underlying medical conditions. Some IVF-related factors, including multiple pregnancy, can also influence pregnancy risk.

This is another reason why singleton embryo transfer and appropriate prenatal care are important.

Does IVF Increase the Risk of Cancer?

It is inappropriate to tell patients that IVF has "no risks" or that there is absolutely no relationship between fertility treatment and any future health outcome.

Large bodies of evidence have not established that standard IVF stimulation causes a general increase in cancer risk for all women. However, individual risk may depend on factors such as age, infertility diagnosis, underlying conditions and the specific treatment history.

Patients with a personal or family history of hormone-sensitive cancers should discuss their individual situation with their physician.

How Long Does IVF Treatment Take?

The active ovarian stimulation phase often lasts approximately 8–14 days, depending on the protocol and ovarian response.

Egg retrieval then takes place after final oocyte maturation is triggered.

If a fresh embryo transfer is planned, transfer may occur several days after egg retrieval.

If embryos are frozen, the transfer is performed during a later cycle.

Therefore, the total treatment timeline varies considerably between patients.

International patients should not assume that every IVF treatment in Turkey can be completed in exactly 10 or 15 days.

How Many IVF Cycles May Be Needed?

There is no universal number of IVF cycles that guarantees success.

Some couples achieve a live birth after their first cycle, while others require multiple attempts.

The decision to repeat treatment should consider:

• Age
• Ovarian reserve
• Number of eggs retrieved
• Fertilization results
• Number and quality of embryos
• Whether blastocysts were obtained
• Previous embryo transfer outcomes
• Uterine factors
• Financial and emotional considerations

After an unsuccessful cycle, the most important step is not simply repeating exactly the same treatment. The physician should review the previous cycle and determine whether there is a medically meaningful reason to modify the strategy.

Lifestyle and Nutrition During IVF

There is no special IVF diet proven to guarantee implantation.

A generally healthy lifestyle is recommended.

Patients may benefit from:

• A balanced Mediterranean-style diet
• Adequate protein and fiber
• Vegetables and fruits
• Whole grains and healthy fats
• Appropriate hydration
• Avoiding smoking
• Avoiding alcohol
• Limiting excessive caffeine
• Regular, moderate physical activity when permitted
• Adequate sleep

Extreme diets, detox programs, herbal products and unproven supplements should not be started without discussing them with the fertility specialist.

Patients should also inform their physician about all medications, vitamins and supplements they use.

What Should International Patients Consider Before IVF in Turkey?

Patients traveling to Turkey for IVF should prepare their medical history before arrival.

Useful documents include:

• Previous IVF reports
• Egg retrieval reports
• Embryology reports
• Semen analyses
• AMH and other ovarian reserve results
• Previous ultrasound reports
• HSG or hysteroscopy reports when available
• Genetic test results
• Previous pregnancy and miscarriage records
• Medication history

It is also useful to ask the clinic for a written treatment plan before traveling.

The patient should know:

1. Which protocol is being proposed?
2. How many days should be spent in Turkey?
3. Can some monitoring be performed in the patient's home country?
4. Who will perform the egg retrieval?
5. Who is responsible for the embryology laboratory?
6. Will conventional IVF or ICSI be used, and why?
7. Is embryo freezing included?
8. Is PGT recommended, and what specific indication supports it?
9. What is the clinic's live-birth rate for patients of a similar age?
10. What happens if no embryo is suitable for transfer?
11. What follow-up is available after returning home?

These questions are often more important than comparing advertised package prices.

IVF Treatment Regulations in Turkey

Assisted reproductive treatment in Turkey is regulated by national legislation and Ministry of Health requirements.

The current regulatory framework specifically describes treatment for eligible married couples and requires appropriate documentation and informed consent.

Turkey also has restrictions regarding the use of reproductive cells and embryos. Therefore, international patients should not assume that procedures legally available in another country are necessarily permitted in Turkey.

Is Donor Egg or Donor Sperm IVF Available in Turkey?

No. Turkey's assisted reproductive treatment framework does not permit routine donor egg, donor sperm or donor embryo treatment.

Treatment is based on the reproductive cells of the couple within the regulatory framework.

Is Gender Selection Legal in Turkey?

Embryo genetic testing can identify sex chromosomes in situations where genetic testing is medically indicated.

However, non-medical sex selection is not permitted as a routine IVF service in Turkey.

Therefore, patients should be cautious about websites advertising elective gender selection as a standard IVF service in Turkey.

Can IVF Be Performed in Azoospermia?

Azoospermia means that sperm are not found in the ejaculate.

It does not always mean that biological fatherhood is impossible.

Depending on the cause of azoospermia, sperm may sometimes be retrieved directly from the epididymis or testicular tissue using procedures such as TESA, TESE or micro-TESE.

If viable sperm can be retrieved, ICSI may be used to fertilize mature oocytes.

The appropriate approach depends on whether the azoospermia is obstructive or non-obstructive and on the patient's hormonal, genetic and testicular findings.

Can IVF Be Performed With Low Ovarian Reserve?

Yes, women with diminished ovarian reserve may still undergo IVF.

However, low ovarian reserve generally means that fewer eggs may be obtained during stimulation.

It is important to understand that low AMH does not mean zero chance of pregnancy, and high AMH does not guarantee pregnancy.

Age and egg quality remain critical factors.

The IVF strategy should therefore be based on the entire clinical picture rather than a single AMH result.

Can IVF Be Performed After Menopause?

The statement that IVF can simply be performed in every woman who has not yet reached menopause is too simplistic.

The possibility and medical appropriateness of IVF depend on ovarian function, availability of usable oocytes, age, uterine status and the applicable legal and medical framework.

As ovarian function declines substantially with age, the probability of obtaining viable embryos using a patient's own oocytes becomes increasingly low.

An individualized fertility assessment is therefore essential.

Can IVF Be Repeated After an Unsuccessful Cycle?

Yes, another IVF cycle may be considered when medically appropriate.

However, repeating treatment should not automatically mean repeating the same protocol.

After an unsuccessful cycle, the physician may review:

• Ovarian response
• Number of mature oocytes
• Fertilization rate
• Embryo development
• Blastocyst formation
• Endometrial findings
• Embryo transfer technique
• Whether any specific medical issue needs to be addressed

A second opinion can also be reasonable when the reason for repeated unsuccessful treatment is unclear.

What Are the Most Important Questions to Ask an IVF Clinic in Turkey?

Before starting treatment, patients should ask:

1. What is my estimated chance of live birth?

Ask for an estimate based on your age and clinical characteristics, not the clinic's overall headline percentage.

2. Which fertilization method will be used?

Ask whether conventional IVF or ICSI is recommended and why.

3. How many embryos are expected to reach the blastocyst stage?

The number of retrieved eggs does not equal the number of usable embryos.

4. Will embryo transfer be fresh or frozen?

Ask what circumstances would change this decision.

5. Is PGT necessary?

PGT should have a specific clinical rationale rather than being automatically added to every IVF package.

6. What is included in the treatment price?

Request a written list of included and excluded services.

7. What happens if the cycle does not produce a transferable embryo?

Understanding this before treatment helps avoid unexpected costs and unrealistic expectations.

Why Choose IVF Treatment in Turkey?

Turkey has a well-established reproductive medicine infrastructure and offers IVF, ICSI, embryo cryopreservation and other assisted reproductive technologies through authorized centers.

For patients considering IVF treatment in Turkey, the most important consideration should be the quality and transparency of care.

A good IVF program should combine:

• Evidence-based medical treatment
• Individualized ovarian stimulation
• Appropriate use of IVF and ICSI
• Experienced embryologists
• High-quality laboratory conditions
• Careful embryo culture
• Appropriate embryo transfer strategy
• Prevention of OHSS
• Transparent reporting of treatment outcomes
• Clear communication with international patients

The goal should never be simply to obtain a positive pregnancy test. The ultimate objective of IVF is a healthy pregnancy resulting in a healthy live birth.

Frequently Asked Questions About IVF Treatment in Turkey

How much does IVF cost in Turkey?

IVF costs vary between clinics and according to the treatment protocol. Medication, ICSI, embryo freezing, storage and PGT may be charged separately. Patients should request an individualized written quotation.

How long do I need to stay in Turkey for IVF?

The required stay depends on whether monitoring is performed locally, whether a fresh or frozen transfer is planned and the patient's response to stimulation. Some international patients may need to remain in Turkey for the stimulation, retrieval and transfer period, while others can complete part of the monitoring in their home country.

Is ICSI included in IVF treatment?

Not necessarily. ICSI is a separate laboratory fertilization technique. It may be recommended for male-factor infertility, previous fertilization failure and selected clinical situations. Routine ICSI is not supported for all patients without male-factor infertility.

Is PGT required for IVF?

No. PGT is not routinely required for every IVF patient. It is primarily considered when there is an appropriate genetic or chromosomal indication or a specific clinical rationale.

Can embryos be frozen?

Yes. Suitable embryos can generally be cryopreserved using vitrification and may be used in future frozen embryo transfer cycles.

Is embryo transfer painful?

Most embryo transfers are performed without anesthesia and are generally well tolerated. Some patients experience mild cramping or discomfort.

When can I take a pregnancy test after IVF?

A blood β-hCG test is generally performed around 9–14 days after embryo transfer, according to the clinic's protocol.

Does IVF guarantee pregnancy?

No. IVF can significantly increase the chance of pregnancy for appropriately selected patients, but it cannot guarantee implantation, pregnancy or live birth.

What is the most important factor affecting IVF success?

Female age is one of the strongest predictors of IVF outcome, but success also depends on ovarian reserve, sperm quality, embryo development, uterine factors, laboratory quality and the underlying cause of infertility.

Can men with azoospermia have biological children through IVF?

In selected cases, yes. If viable sperm can be surgically retrieved from the reproductive tract or testicular tissue, ICSI may be used for fertilization.

Is gender selection available with IVF in Turkey?

Non-medical sex selection is not offered as a routine IVF service in Turkey. Genetic testing may identify sex chromosomes when testing is performed for an appropriate medical indication.

Can unmarried couples receive IVF treatment in Turkey?

Turkey's regulatory framework defines assisted reproductive treatment within the framework of married couples and requires appropriate documentation.

Final Considerations

IVF treatment in Turkey should be approached as an individualized medical treatment rather than a standardized package.

The most important factors are not simply the number of eggs retrieved or the clinic's advertised pregnancy rate. A comprehensive IVF strategy considers the patient's age, ovarian reserve, infertility diagnosis, sperm parameters, embryo development, laboratory quality, endometrial conditions and the safest embryo transfer strategy.

Current international guidance increasingly emphasizes individualized ovarian stimulation, prevention of complications, evidence-based use of laboratory techniques and the goal of a healthy singleton live birth. The 2025 ESHRE ovarian stimulation guideline and updated ASRM guidance on ICSI reflect this movement toward more personalized and evidence-based IVF care.

For patients considering IVF in Turkey, the best starting point is a detailed consultation with an appropriately qualified fertility specialist who can review the couple's medical history and develop a treatment plan based on their individual circumstances.

Scientific and Regulatory References

• European Society of Human Reproduction and Embryology (ESHRE) – Guideline on Ovarian Stimulation for IVF/ICSI. (ESHRE)
• American Society for Reproductive Medicine (ASRM) – Intracytoplasmic sperm injection for nonmale factor indications, 2026. (ASRM)
• ASRM – The use of preimplantation genetic testing for aneuploidy, 2024. (ASRM)
• ESHRE – Guideline on the number of embryos to transfer during IVF/ICSI. (ESHRE)
• U.S. Centers for Disease Control and Prevention (CDC) – Assisted Reproductive Technology national data. (Hastalık Kontrol ve Önleme Merkezleri)
• Republic of Türkiye Ministry of Health – Regulation on Assisted Reproductive Treatment Practices and Assisted Reproductive Treatment Centers. (Sağlık Bakanlığı)